Featured content in this Issue: Companies, organisations and drug candidates mentioned in this Bulletin: Lykos Therapeutics, MDMA-assisted therapy; Compass Pathways; COMP360; MHRA; Beckley Psytech; BPL-003; GH Research; GH001; Numinus; PharmAla Biotech; NIDA; MindBio. This is the first issue of our Psychedelic Bulletin that’s exclusively for Pα+ subscribers. Head to our Join page to…

Source

Previous articleThe Practitioner’s Guide to Psychedelic Integration Therapy
Next articlePT499 – Mesoamerican Psychedelics, Decolonization, and the Concept of an Ontological Turn